Related Experiment Video
Updated: Mar 24, 2026

Detection of Antibodies That Neutralize the Cellular Uptake of Enzyme Replacement Therapies with a Cell-based Assay
Published on: September 10, 2018
ATYPICAL HEMOLYTIC UREMIC SYNDROME IN AN ADULT SUCCESSFULLY TREATED WITH ECULIZUMAB
Catherine Chaudoir1, Menchu G Ong2, Xin Gu3
1Dr Chardoir is affiliated with the Louisiana State University Health Sciences Center at Shreveport Department of Pathology.
Abstract:
Atypical Hemolytic Uremic Syndrome is a triad of microangiopathic hemolytic anemia, thrombocytopenia and acute renal failure not associated with diarrhea. It is a rare condition associated with complement disorders in about 50 percent of cases. The first line of treatment is therapeutic plasma exchange. However, because clinical response to TPE varies, an anti-complement drug, eculizumab has been tried. We report a case of atypical HUS successfully treated with eculizumab.
Related Concept Videos
Hypersensitivity Reactions: Cytolytic Reactions
Nephrotic Syndrome II : Assessment and Medical Management
